Molecular profiling of indigenous African CRC samples compared with US self-identified Black/African Ancestry (AA) and White/European Ancestry (EA) CRC samples

This project addresses molecular differences in colorectal adenocarcinoma across populations by profiling tumors from indigenous African patients and comparing them with United States self-identified Black/African Ancestry (AA) and White/European Ancestry (EA) patients. The work focuses on how African continental ancestry and deficiency in DNA mismatch-repair enzymes or microsatellite instability-high (MMR-deficient/MSI-high) status influence immune-related gene expression in colorectal cancer. By centering ancestry and MMR/MSI status, the study seeks to clarify relationships between genetic background, tumor molecular phenotype, and immune gene expression patterns without presupposing outcomes. The title and author list indicate an emphasis on comprehensive gene expression analysis in colorectal adenocarcinoma and on the intersection of ancestry and DNA repair deficiencies as modulators of tumor immune biology.

The research is positioned to contribute to a comparative molecular profiling framework that recognizes continental ancestry as a biologically relevant variable for tumor characterization. By explicitly comparing indigenous African colorectal cancer samples with AA and EA CRC samples from the United States, the study aims to illuminate distinctions and commonalities in tumor immune gene expression that may be associated with ancestry or with MMR/MSI status. The focus on MMR deficiency and MSI-high status highlights a biologically important tumor feature known to shape neoantigen burden and immune infiltration; here, the project examines how these features interact with ancestry to influence immune gene expression signatures in colorectal adenocarcinoma. Although the excerpt does not provide experimental details, cohort sizes, or specific findings, the conceptual framework presented in the title and author information indicates an integrated molecular and immunogenomic approach to understanding colorectal cancer heterogeneity across populations.

Framing this work as part of a broader effort to enhance molecular characterization of cancer across diverse populations, the study advances questions relevant to precision oncology and health equity. Investigating tumor immune gene expression in the context of both ancestry and MMR/MSI status can help identify population-specific molecular patterns that may affect prognosis, response to immunotherapy, or biomarker development.

Overall, this comparative molecular profiling project highlights the importance of including indigenous African samples alongside US AA and EA cohorts to generate a more complete, ancestry-informed understanding of colorectal adenocarcinoma immune gene expression, particularly in relation to MMR deficiency and MSI-high status. Such work lays groundwork for subsequent hypothesis-driven studies, clinical validation and potential translation into ancestry-aware clinical strategies for colorectal cancer management.